zingerone has been researched along with Fatty Liver, Nonalcoholic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mohammed, HM | 1 |
| Jesudoss, VA; Muniandy Narayanan, J | 1 |
2 other study(ies) available for zingerone and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Zingerone ameliorates non-alcoholic fatty liver disease in rats by activating AMPK.
Topics: AMP-Activated Protein Kinases; Animals; Guaiacol; NF-E2-Related Factor 2; NF-kappa B; Non-alcoholic Fatty Liver Disease; Rats | 2022 |
Hepatoprotective potential of zingerone against nonalcoholic fatty liver disease in rats fed with fructose-enriched diet.
Topics: Animals; Antioxidants; Dietary Sucrose; Fructose; Guaiacol; Lipid Metabolism; Liver; Male; Non-alcoholic Fatty Liver Disease; Protective Agents; Rats; Rats, Wistar; Treatment Outcome | 2016 |